10 Stocks That Will Change the World by 2030
Artificial intelligence, robotics and gene editing are moving from research demonstrations into products that can alter how people work, manufacture goods and receive treatment.
Nupathe Inc. (PATH)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (PATH) is currently associated with the following stock: Uipath Inc. (PATH)
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Sabby Capital Hal Mintz | 0 | $0 | 0% | |
| 3. | Amici Capital Paul Orlin And Alex Porter | 0 | $0 | 0% | |
| 4. | Green Arrow Capital Management Millennium Management Subsidiary | 0 | $0 | 0% | |
| 5. | Twin Capital Management David Simon | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.68 | 10,000 | $26,799.00 | 10,000 | 2011-09-15 | Filing | |
| $2.56 | 20,000 | $51,286.00 | 213,600 | 2011-09-09 | Filing | |
| $2.49 | 7,500 | $18,674.25 | 7,500 | 2011-09-07 | Filing | |
| $10.00 | 29,359 | $293,590.00 | 1,433,429 | 2010-08-11 | Filing | |
| $10.00 | 264,231 | $2,642,310.00 | 1,404,070 | 2010-08-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.39 | 37,593 | $127,440.27 | 268,879 | 2012-10-17 | Filing | |
| $3.29 | 72,407 | $238,219.03 | 306,472 | 2012-10-16 | Filing | |
| $3.37 | 113,000 | $380,810.00 | 378,879 | 2012-10-15 | Filing |
News See All
Salesforce vs. UiPath: Which AI Automation Stock Gives Investors More for Their Money?
UiPath costs about $13 a share. Salesforce costs more than $230.
10 Best AI Stocks to Buy Under $25
Artificial intelligence is moving into the ordinary software and services that businesses already buy.
UiPath (PATH) Gets Two Price Target Cuts: Is the Growth Story at Risk?
On September 22, UBS cut its price target on UiPath, Inc. (NYSE:PATH) from $19 to $15 and kept its Neutral rating on the stock.
A Philippine Telecom's AI Makeover Tests UiPath's (PATH) Pitch
On September 11, UiPath (NYSE:PATH) announced that PLDT, the leading digital services provider in the Philippines, had scaled its use of the UiPath Platform to keep pace with surging demand from 5G rollout...
UiPath, Inc. (PATH) Stock Has AI Potential, But Slowing Growth Keeps Investors Cautious
UiPath, Inc. (NYSE:PATH) has underperformed the broader market year to date, with shares materially down for the year.
UiPath Stock (PATH) Falls on Weak Guidance; Canaccord Downgrades Rating to Hold
UiPath ($PATH) stock plunged about 16% at the time of writing on Friday, as the automation software company’s fiscal third-quarter guidance implied...
UiPath (PATH) Grew ARR 12% as Net Retention Rate Reached 109%. Can Agentic Automation Reaccelerate Expansion?
UiPath, Inc. (NYSE:PATH) reported fiscal second-quarter revenue of $410.3 million, up 13% year over year, while annualized renewal run-rate, or ARR, rose 12% to $1.938 billion. UiPath, Inc.
Options Volatility and Implied Earnings Moves Today, September 03, 2026
Today, several major companies are expected to report earnings: Ciena (CIEN), Lululemon Athletica (LULU), Ambarella (AMBA), Hello Group (MOMO), Zsc...
UiPath Stock (PATH) Set For Near 14% Move After Q2 Earnings Tomorrow, Say Options Traders
UiPath ($PATH) reports its Q2 earnings tomorrow – September 3. The Robotic Process Automation company has seen its share price climb 10% despite pr...